title: Pituitary apoplexy after somatostatin analogue administration: coincidental or causative?
authors.affiliation: Department of Endocrinology, Centre Hospitalier Departemental Felix Guyon, St Denis, France.
authors.forename: Fawzi
authors.initials: F
authors.lastname: Bakiri
authors.forename: Javier
authors.initials: J
authors.lastname: Herrera
authors.forename: Maria
authors.initials: M
authors.lastname: Riestra
authors.forename: Olivier
authors.initials: O
authors.lastname: Perrichot
authors.forename: Joaquin
authors.initials: J
authors.lastname: Pertierra
authors.forename: Oscar Domingo
authors.initials: OD
authors.lastname: Bruno
authors.forename: Thierry
authors.initials: T
authors.lastname: Brue
authors.forename: Frederic
authors.initials: F
authors.lastname: Castinetti
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010899:Pituitary Apoplexy / Q000139:chemically induced / Q000175:diagnosis* / Q000209:etiology; D010911:Pituitary Neoplasms / Q000188:drug therapy; D013004:Somatostatin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D013004:Somatostatin